Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100053264Phase 4Recruiting
Phase 4, randomised, open-label trial of influenza vaccine in heart failure (HF) (2 arms), sponsored by Heart Health Research Center. Primary endpoint: Composite of all-cause death and all-cause hospitalization at 1 year. Started Dec 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100053264.